Cambridge Cancer Genomics
Nirmesh spearheads the clinical research and establishes experimental developments at CCG, sitting at the interface between clinical collaborators and the lab. He brings a deep understanding of the clinical applications of cancer biology, with a background in translational cancer medicine and novel therapeutic development through his PhD at King’s College London and the Institute of Cancer Research.
This person is not in any offices
Cambridge Cancer Genomics
1 followers
CCG builds precision oncology solutions for all patients. Our technology can detect relapse earlier than standard of care, predict response to therapy more accurately & reduce ineffective treatment regimens.